Examining recombinant human TSH primed 131I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocol

Simple item page
dc.contributor.authorRani, D.
dc.contributor.authorKaisar, S.
dc.contributor.authorAwasare, S.
dc.contributor.authorKamaldeep
dc.contributor.authorAbhyankar, A.
dc.contributor.authorBasu, Sandip
dc.date.accessioned2015-01-20T05:57:14Z
dc.date.available2015-01-20T05:57:14Z
dc.date.issued2014
dc.description.divisionRMCen
dc.format.extent8881 bytes
dc.format.mimetypetext/html
dc.identifier.sourceEuropean Journal of Nuclear Medicine & Molecular Imaging, 2014. Vol. 41 (9): pp. 1767-1780en
dc.identifier.urihttp://hdl.handle.net/123456789/10256
dc.language.isoenen
dc.subjectRecombinant human thyroid stimulating hormoneen
dc.subjectDifferentiated thyroid carcinomaen
dc.subjectMetastasisen
dc.subjectRadiation absorbed doseen
dc.subjectEffective half-lifeen
dc.subjectQuality of lifeen
dc.titleExamining recombinant human TSH primed 131I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocolen
dc.typeArticleen

Click here to download

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
0493.htm
Size:
8.67 KB
Format:
Hypertext Markup Language
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.81 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

2014